Intersect Ent Inc
NASDAQ:XENT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Intersect Ent Inc
Net Issuance of Common Stock
Intersect Ent Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Intersect Ent Inc
NASDAQ:XENT
|
Net Issuance of Common Stock
$7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Issuance of Common Stock
-$500m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Issuance of Common Stock
$199m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Net Issuance of Common Stock
-$674m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
12%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Issuance of Common Stock
$310.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
See Also
What is Intersect Ent Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
7m
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Net Issuance of Common Stock amounts to 7m USD.
What is Intersect Ent Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
30%
Over the last year, the Net Issuance of Common Stock growth was 42%. The average annual Net Issuance of Common Stock growth rates for Intersect Ent Inc have been -19% over the past three years , 30% over the past five years .